These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38646521)

  • 81. An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells.
    Sung AP; Tang JJ; Guglielmo MJ; Redelman D; Smith-Gagen J; Bateman L; Hudig D
    J Immunol Methods; 2018 Jan; 452():63-72. PubMed ID: 29113954
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Afucosylated antibodies increase activation of FcγRIIIa-dependent signaling components to intensify processes promoting ADCC.
    Liu SD; Chalouni C; Young JC; Junttila TT; Sliwkowski MX; Lowe JB
    Cancer Immunol Res; 2015 Feb; 3(2):173-83. PubMed ID: 25387893
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A Tridimensional Model for NK Cell-Mediated ADCC of Follicular Lymphoma.
    Decaup E; Rossi C; Gravelle P; Laurent C; Bordenave J; Tosolini M; Tourette A; Perrial E; Dumontet C; Poupot M; Klein C; Savina A; Fournié JJ; Bezombes C
    Front Immunol; 2019; 10():1943. PubMed ID: 31475004
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Anti-CD20 rituximab IgG1, IgG3, and IgG4 but not IgG2 subclass trigger Ca
    Freitas Monteiro M; Papaserafeim M; Réal A; Puga Yung GL; Seebach JD
    J Leukoc Biol; 2020 Oct; 108(4):1409-1423. PubMed ID: 32620047
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Membrane-type 6 matrix metalloproteinase regulates the activation-induced downmodulation of CD16 in human primary NK cells.
    Peruzzi G; Femnou L; Gil-Krzewska A; Borrego F; Weck J; Krzewski K; Coligan JE
    J Immunol; 2013 Aug; 191(4):1883-94. PubMed ID: 23851692
    [TBL] [Abstract][Full Text] [Related]  

  • 86. ADCC employing an NK cell line (haNK) expressing the high affinity CD16 allele with avelumab, an anti-PD-L1 antibody.
    Jochems C; Hodge JW; Fantini M; Tsang KY; Vandeveer AJ; Gulley JL; Schlom J
    Int J Cancer; 2017 Aug; 141(3):583-593. PubMed ID: 28477372
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity.
    Mandelboim O; Malik P; Davis DM; Jo CH; Boyson JE; Strominger JL
    Proc Natl Acad Sci U S A; 1999 May; 96(10):5640-4. PubMed ID: 10318937
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies.
    Cheng ZJ; Garvin D; Paguio A; Moravec R; Engel L; Fan F; Surowy T
    J Immunol Methods; 2014 Dec; 414():69-81. PubMed ID: 25086226
    [TBL] [Abstract][Full Text] [Related]  

  • 89. In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma.
    Gandoglia I; Ivaldi F; Carrega P; Armentani E; Ferlazzo G; Mancardi G; Kerlero de Rosbo N; Uccelli A; Laroni A
    Immunol Lett; 2017 Jan; 181():109-115. PubMed ID: 27919749
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Small-Molecule Immunosuppressive Drugs and Therapeutic Immunoglobulins Differentially Inhibit NK Cell Effector Functions
    Pradier A; Papaserafeim M; Li N; Rietveld A; Kaestel C; Gruaz L; Vonarburg C; Spirig R; Puga Yung GL; Seebach JD
    Front Immunol; 2019; 10():556. PubMed ID: 30972058
    [TBL] [Abstract][Full Text] [Related]  

  • 91. An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele.
    Jochems C; Hodge JW; Fantini M; Fujii R; Morillon YM; Greiner JW; Padget MR; Tritsch SR; Tsang KY; Campbell KS; Klingemann H; Boissel L; Rabizadeh S; Soon-Shiong P; Schlom J
    Oncotarget; 2016 Dec; 7(52):86359-86373. PubMed ID: 27861156
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Activation of CD16+ effector cells by rheumatoid factor complex. Role of natural killer cells in rheumatoid arthritis.
    Hendrich C; Kuipers JG; Kolanus W; Hammer M; Schmidt RE
    Arthritis Rheum; 1991 Apr; 34(4):423-31. PubMed ID: 1707275
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activation.
    Tang CC; Isitman G; Bruneau J; Tremblay C; Bernard NF; Kent SJ; Parsons MS
    Clin Exp Immunol; 2015 Aug; 181(2):275-85. PubMed ID: 25644502
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines.
    Roda JM; Joshi T; Butchar JP; McAlees JW; Lehman A; Tridandapani S; Carson WE
    Clin Cancer Res; 2007 Nov; 13(21):6419-28. PubMed ID: 17962339
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Immunological changes in the ascites of cancer patients after intraperitoneal administration of the bispecific antibody catumaxomab (anti-EpCAM×anti-CD3).
    Fossati M; Buzzonetti A; Monego G; Catzola V; Scambia G; Fattorossi A; Battaglia A
    Gynecol Oncol; 2015 Aug; 138(2):343-51. PubMed ID: 26049121
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Glycolysis and Oxidative Phosphorylation Play Critical Roles in Natural Killer Cell Receptor-Mediated Natural Killer Cell Functions.
    Wang Z; Guan D; Wang S; Chai LYA; Xu S; Lam KP
    Front Immunol; 2020; 11():202. PubMed ID: 32153568
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Ovarian Cancer-Associated Ascites Have High Proportions of Cytokine-Responsive CD56bright NK Cells.
    Tonetti CR; de Souza-Araújo CN; Yoshida A; da Silva RF; Alves PCM; Mazzola TN; Derchain S; Fernandes LGR; Guimarães F
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359872
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Adhesion of CD16+ K cells to antibody-coated targets is mediated by CD2 and CD18 receptors.
    Voltarelli JC; Gjerset G; Anasetti C
    Immunology; 1993 Jul; 79(3):509-11. PubMed ID: 8104886
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells
    Pham DH; Kim JS; Kim SK; Shin DJ; Uong NT; Hyun H; Yoon MS; Kang SJ; Ryu YJ; Cho JS; Yoon JH; Lee JS; Cho D; Lee SH; Park MH
    Anticancer Res; 2017 Oct; 37(10):5507-5513. PubMed ID: 28982863
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Impaired natural killer cell-induced antibody-dependent cell-mediated cytotoxicity is associated with human immunodeficiency virus-1 disease progression.
    Jia M; Li D; He X; Zhao Y; Peng H; Ma P; Hong K; Liang H; Shao Y
    Clin Exp Immunol; 2013 Jan; 171(1):107-16. PubMed ID: 23199330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.